Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Proteinuria
MeSH D011507 - proteinuria
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D014555:
Urination disorders
6 Companies
3 Drugs
$
Success rate
D020924:
Urological manifestations
2 Companies
4 Drugs
$
Success rate
D011507:
Proteinuria
1 Company
1 Drug
$
Success rate
D000419:
Albuminuria
0 Companies
0 Drugs
Success rate
D006456:
Hemoglobinuria
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
83
%
5/6
Phase 2
29
%
5/17
Phase 3
29
%
7/24
Approved:
0
Overall Success rate:
7%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Travere Therapeutics
Sparsentan
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use